Delivery Order SPE2DR25D2014-SPE2DR26FA0W3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,443.56 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens on November 6, 2025, with completion targeted for November 7, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $2,028.06 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens on a firm fixed price basis. The award was issued on December 29, 2025, with an ultimate completion date of December 30, 2025. This non-competitive delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for...
- The Defense Logistics Agency awarded a delivery order valued at $2,733.38 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on a firm fixed-price basis. The award, made on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a non-set-aside, competitively awarded contract. AmerisourceBergen will perform from its corporate office location in Conshohocken, Pennsylvania, fulfilling this pharmaceutical delivery order as part of the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $1,744.44 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL dosage) on December 16, 2025, with an ultimate completion date of December 17, 2025. This competitive award carries firm fixed price terms and involves no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens valued at $1,772.87 with a completion date of July 31, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $1,239.95 to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on December 9, 2025, with a completion date of December 10, 2025. This firm fixed price, non-set-aside contract represents a competitive award for pharmaceutical supply to support federal medical procurement needs. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a major...
- The Defense Logistics Agency awarded a delivery order valued at $3,164.60 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL) under a firm fixed-price contract type. The award was made on December 19, 2025, with an ultimate completion date of December 22, 2025. This non-competitive delivery order will be fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a $1,801.80 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 ml pens on September 19, 2025, with completion scheduled for September 22, 2025. This firm fixed-price delivery order represents a non-set-aside award issued to support federal pharmaceutical supply needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and veteran healthcare systems...
- The Defense Logistics Agency awarded a $11,264.56 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 ml pens on December 20, 2025, with completion scheduled for December 22, 2025. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $1,898.88 to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 ml pens on December 29, 2025, with completion scheduled for December 30, 2025. This non-competitive, firm fixed-price delivery order represents a standard pharmaceutical procurement under the company's broader federal contract portfolio. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FA0W3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,263.00 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens (0.5 ml) under a firm fixed price contract. The award was made on December 29, 2025, with an ultimate completion date of December 30, 2025. This delivery order is not set-aside and represents a competitively awarded transaction for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for the Defense Logistics Agency's Medical Supply Chain and will perform this order at its corporate office location. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This comprehensive IDC serves as a global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to support military healthcare programs worldwide, including support to the Defense Health Agency and U.S. Coast Guard. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical procurement requirements, from diabetes medications to specialty treatments, across multiple therapeutic domains for federal medical systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 12/28/25 |